Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 37.94 M45.01 M51.43 M46.17 M 180.54 M Research & development ———— — Operating income 128.39 M183.41 M264.33 M234.1 M 810.24 M Non-Operating Income, Total 15.26 M19.31 M18.77 M20.44 M 73.79 M Interest expense, net of interest capitalized 895 K909 K892 K1.05 M 3.75 M Non-Operating Income, excl. Interest Expenses 14.36 M18.41 M17.88 M19.39 M 70.04 M Unusual income/expense ———— — Pretax income 96.3 M147.01 M222.02 M185.68 M 651.01 M Equity in earnings ———— — Taxes 26.23 M36.02 M51.63 M46.15 M 160.03 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 70.07 M111 M170.39 M139.53 M 490.98 M Discontinued operations ———— — Net income 70.07 M111 M170.39 M139.53 M 490.98 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 70.07 M111 M170.39 M139.53 M 490.98 M Basic earnings per share (Basic EPS) 1.050.891.181.13 4.25 Diluted earnings per share (Diluted EPS) 0.560.791.261.02 3.63 Average basic shares outstanding 66.77 M125.25 M93.37 M123.34 M — Diluted shares outstanding 66.77 M140.11 M131.96 M136.59 M — EBITDA 130.51 M185.63 M266.7 M234.63 M 817.47 M EBIT 127.5 M182.5 M263.44 M233.25 M 806.69 M Cost of revenue -32.1 M-36.39 M-42.31 M-48.42 M -159.23 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 3.01 M3.13 M3.26 M1.38 M 10.79 M